Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma

Clinical Cancer Research

Volumn 9, Issue 9, 2003, Pages 3406-3412

  Ding, Yongzeng ^a   Shimada, Yutaka ^a   Maeda, Masato ^a   Kawabe, Atsushi ^a   Kaganoi, Junichi ^a   Komoto, Izumi ^a   Hashimoto, Yosuke ^a   Miyake, Masayuki ^b   Hashida, Hiroki ^b   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; F ACTIN; LIGAND; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASSAY; CANCER CELL; CANCER CELL CULTURE; CANCER SURVIVAL; CELL MIGRATION; CELL MOTILITY; CHEMOTAXIS; DENDRITIC CELL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOPODIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; DENDRITIC CELLS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LYMPHATIC METASTASIS; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS;

EID: 10744226186     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sugimachi, K., Matsuoka, H., Ohno, S., Mori, M., and Kuwano, H. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. Br. J. Surg., 75: 1115-1118, 1998.
2. Isono, K., Sato, H., and Nakayama, K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology, 48: 411-420, 1991.
3. Baggiolini, M., Dewald, B., and Moser, B. Human chemokines: an update. Annu. Rev. Immunol., 15: 675-705, 1997.
4. Rollins, B. J. Chemokines. Blood, 90: 909-928, 1997.
5. Kelner, G. S., Kennedy, J., Bacon, K. B., Kleyensteuber, S., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., Bazan, J. F., Moore, K. W., and Schall, T. J. Lymphotactin: a cytokine that represents a new class of chemokine. Science (Wash. DC), 266: 1395-1399, 1994.
6. Rottman, J. B. Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease. Vet. Pathol., 36: 357-367, 1999.
7. Rossi, D., and Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol., 18: 217-242, 2000.
8. Hasegawa, H., Nomura, T., Kohno, M., Tateishi, N., Suzuki, Y., Maeda, N., Fujisawa, R., Yoshie, O., and Fujita, S. Increased chemokine receptor CCR7/ EBII expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood, 95: 30-38, 2000.
9. Hopke, U. E., Foss, H. D., Meyer, D., Hinz, M., Leder, K., Stein, H., and Lipp, M. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood, 99: 1109-1116, 2002.
10. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan ME., McClanahan T., Murphy E., Yuan W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.), 410: 50-56, 2001.
11. Mashino, K., Sadanaga, N., Yamaguchi, H., Tanaka, F., Ohta, M., Shibuta, K., Inoue, H., and Mori, M. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res., 62: 2937-2941, 2002.
12. Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M. T., and Hwang, S. T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. (Bethesda), 93: 1638-1643, 2001.
13. Imamura, M., Ohishi, K., Mizutani, N., Yanagibashi, K., Naito, M., Shimada, Y., Hattori, Y., Satomura, K., and Tobe, T. Retrosternal esophagogastrostomy with EEA staple after subtotal resection of the esophagus: application and results. Dig. Surg., 4: 101-105, 1987.
14. Sobin, L. H., and Wittekind, C., (eds.). TNM Classification of Malignant Tumors. International Union Against Cancer, Ed. 5. New York: Wiley-Liss, 1997.
15. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N., and Tobe, T. Characterization of 21 newly established esophageal cancer cell lines. Cancer (Phila.), 69: 277-284, 1992.
16. Krajewska, M., Krajewski, S., Epstein, J. L., Shabaik, A., Sauvageot, J., Song, K., Kitada, S., and Reed, J. C. Immunohistochemical analysis of bcl-2, bax, and mcl-1 expression in prostate cancers. Am. J. Pathol., 148: 1567-1576, 1996.
17. Albrecht-Buehler, G. The phagokinetic tracks of 3T3 cells. Cell, 11: 395-404, 1977.
18. Yoshida, R., Imai, T., Hieshima, K., Kusuda, J., Baba, M., Kitaura, M., Nishimura, M., Kakizaki, M., Nomiyama, H., and Yoshie, O. Molecular cloning of a novel human CC chemokine EBII-ligand chemokine that is a specific functional ligand for EBII, CCR7. J. Biol. Chem., 272: 13803-13809, 1997.
19. Baggiolini, M. Chemokines and leukocyte traffic. Nature (Lond.), 392: 565-568, 1998.
20. Nicolson, G. L. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev., 12: 325-343, 1993.
21. Wang, J. M., Deng, X., Gong, W., and Su, S. Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods. 220: 1-17, 1998.
22. Zlotnik, A., and Yoshie, O. Chemokines: a new classification system and their role in immunity. Immunity, 12: 121-127, 2000.
23. Campbell, J. J., and Butcher, E. C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol., 12: 336-341, 2000.
24. Hedrick, J. A., and Zlotnik, A. Identification and characterization of a novel β chemokine containing six conserved cysteines. J. Immunol., 159: 1589-1593, 1997.
25. Campbell, J. J., Hedrick, J., Zlotnik, A., Siani, M. A., Thompson, D. A., and Butcher, E. C. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science (Wash. DC), 279: 381-384, 1998.
26. Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., and Nakano, H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med., 189: 451-460, 1999.
27. Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., and Williams, L. T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA, 95: 258-263, 1998.
28. Vassileva, G., Soto, H., Zlotnik, A., Nakano, H., Kakiuchi, T., Hedrick, J. A., and Lira, S. A. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med., 18: 1183-1188, 1999.
29. Saeki, H., Moore, A. M., Brown, M. J., and Hwang, S. T. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol., 162: 2472-2475, 1999.
30. Till, K. J., Lin, K., Zuzel, M., and Cawley, J. C. The chemokine receptor CCR7 and α4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood, 99: 2977-2984, 2002.
31. Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., Fujii, N., and Imamura, M. Expression of stromal cell-derived factor I and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res., 6: 3530-3535, 2000.
32. Taichman, R. S., Cooper, C., Keller, E. T., Pienta, K. J., Taichman, N. S., and McCauley, L. K. Use of the stromal cell-derived factor-1/ CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res., 62: 1832-1837, 2002.
33. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., and Balkwill, F. R. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res., 61: 4961-4965, 2001.
34. Balkwill, F., and Mantovani, A. Inflammation and cancer: back to Virchow. Lancet, 357: 539-545, 2001.